CDC-Authored Genomics and Precision Health Publications Database

---

Last data update: Jan 27, 2025. (Total: 6504 publications)

All Cancer Diabetes Economic Environmental Equity FHH HLBS ID Implementation ND PGx PI Rare RCH dataset

Filtered By: Select to fine-tune your search Year Journal

Records 1-17 (of 17 Records)

Query Trace: Pallansch MA[original query]
Coordinated global cessation of oral poliovirus vaccine use: Options and potential consequences Kalkowska DA , Wassilak SGF , Wiesen E , Burns CC , Pallansch MA , Badizadegan K , Thompson KM . Risk Anal 2023
Worst-case scenarios: Modeling uncontrolled type 2 polio transmission Kalkowska DA , Wiesen E , Wassilak SGF , Burns CC , Pallansch MA , Badizadegan K , Thompson KM . Risk Anal 2023
Immunogenicity of novel oral poliovirus vaccine type 2 administered concomitantly with bivalent oral poliovirus vaccine: an open-label, non-inferiority, randomised, controlled trial Wilkinson AL , Zaman K , Hoque M , Estivariz CF , Burns CC , Konopka-Anstadt JL , Mainou BA , Kovacs SD , An Q , Lickness JS , Yunus M , Snider CJ , Zhang Y , Coffee E , Abid T , Wassilak SGF , Pallansch MA , Oberste MS , Vertefeuille JF , Anand A . Lancet Infect Dis 2023 23 (9) 1062-1071
Serotype 2 oral poliovirus vaccine (OPV2) choices and the consequences of delaying outbreak response. Kalkowska DA , Pallansch MA , Wassilak SGF , Cochi SL , Thompson KM . Vaccine 2021 41 Suppl 1 A136-A141
Updated Characterization of Outbreak Response Strategies for 2019-2029: Impacts of Using a Novel Type 2 Oral Poliovirus Vaccine Strain. Kalkowska DA , Pallansch MA , Wilkinson A , Bandyopadhyay AS , Konopka-Anstadt JL , Burns CC , Oberste MS , Wassilak SGF , Badizadegan K , Thompson KM . Risk Anal 2020 41 (2) 329-348
Updated Characterization of Post-OPV Cessation Risks: Lessons from 2019 Serotype 2 Outbreaks and Implications for the Probability of OPV Restart. Kalkowska DA , Pallansch MA , Cochi SL , Kovacs SD , Wassilak SGF , Thompson KM . Risk Anal 2020 41 (2) 320-328
ICTV Virus Taxonomy Profile: Picornaviridae. Zell R , Delwart E , Gorbalenya AE , Hovi T , King AMQ , Knowles NJ , Lindberg AM , Pallansch MA , Palmenberg AC , Reuter G , Simmonds P , Skern T , Stanway G , Yamashita T , Ictv Report Consortium . J Gen Virol 2017 98 (10) 2421-2422
The role of supplementary environmental surveillance to complement acute flaccid paralysis surveillance for wild poliovirus in Pakistan - 2011-2013. Cowger TL , Burns CC , Sharif S , Gary HE Jr , Iber J , Henderson E , Malik F , Zahoor Zaidi SS , Shaukat S , Rehman L , Pallansch MA , Orenstein WA . PLoS One 2017 12 (7) e0180608
Patients with Primary Immunodeficiencies Are a Reservoir of Poliovirus and a Risk to Polio Eradication. Aghamohammadi A , Abolhassani H , Kutukculer N , Wassilak SG , Pallansch MA , Kluglein S , Quinn J , Sutter RW , Wang X , Sanal O , Latysheva T , Ikinciogullari A , Bernatowska E , Tuzankina IA , Costa-Carvalho BT , Franco JL , Somech R , Karakoc-Aydiner E , Singh S , Bezrodnik L , Espinosa-Rosales FJ , Shcherbina A , Lau YL , Nonoyama S , Modell F , Modell V , Ozen A , Berlin A , Chouikha A , Partida-Gaytán A , Kiykim A , Prakash C , Suri D , Ayvaz DC , Peláez D , da Silva EE , Deordieva E , Pérez-Sánchez EE , Ulusoy E , Dogu F , Seminario G , Cuzcanci H , Triki H , Shimizu H , Tezcan I , Ben-Mustapha I , Sun J , Mazzucchelli JTL , Orrego JC , Pac M , Bolkov M , Giraldo M , Belhaj-Hmida N , Mekki N , Kuzmenko N , Karaca NE , Rezaei N , Diop OM , Baris S , Chan SM , Shahmahmoodi S , Haskologlu S , Ying W , Wang Y , Barbouche MR , McKinlay MA . Front Immunol 2017 8 685
Development of an efficient entire-capsid-coding-region amplification method for direct detection of poliovirus from stool extracts. Arita M , Kilpatrick DR , Nakamura T , Burns CC , Bukbuk D , Oderinde SB , Oberste MS , Kew OM , Pallansch MA , Shimizu H . J Clin Microbiol 2014 53 (1) 73-8
Detection of vaccine-derived polioviruses in Mexico using environmental surveillance. Esteves-Jaramillo A , Estivariz CF , Penaranda S , Richardson VL , Reyna J , Coronel DL , Carrion V , Landaverde JM , Wassilak SG , Perez-Sanchez EE , Lopez-Martinez I , Burns CC , Pallansch MA . J Infect Dis 2014 210 Suppl 1 S315-23
Switch from oral to inactivated poliovirus vaccine in Yogyakarta Province, Indonesia: summary of coverage, immunity, and environmental surveillance. Wahjuhono G , Revolusiana , Widhiastuti D , Sundoro J , Mardani T , Ratih WU , Sutomo R , Safitri I , Sampurno OD , Rana B , Roivainen M , Kahn AL , Mach O , Pallansch MA , Sutter RW . J Infect Dis 2014 210 Suppl 1 S347-52
Diversity of picornaviruses in rural Bolivia Nix WA , Khetsuriani N , Penaranda S , Maher K , Venczel L , Cselko Z , Freire MC , Cisterna D , Lema C , Rosales P , Rodriguez J , Rodriguez W , Halkyer P , Ronveaux O , Pallansch MA , Oberste M . J Gen Virol 2013 94 2017-2028
Naturally acquired picornavirus infections in nonhuman primates at the Dhaka Zoo Oberste MS , Feeroz MM , Maher K , Nix WA , Engel GA , Begum S , Hasan KM , Oh G , Pallansch MA , Jones-Engel L . J Virol 2012 87 (1) 572-80
Characterization of poliovirus variants selected for resistance to the antiviral compound V-073 Liu H , Roberts JA , Moore D , Anderson B , Pallansch MA , Pevear DC , Collett MS , Oberste MS . Antimicrob Agents Chemother 2012 56 (11) 5568-74
Parechovirus typing in clinical specimens by nested or semi-nested PCR coupled with sequencing Nix WA , Maher K , Pallansch MA , Oberste MS . J Clin Virol 2010 48 (3) 202-7
Shedding of vaccine viruses with increased antigenic and genetic divergence after vaccination of newborns with monovalent type 1 oral poliovirus vaccine van der Sanden S , Pallansch MA , van de Kassteele J , El-Sayed N , Sutter RW , Koopmans M , van der Avoort H . J Virol 2009 83 (17) 8693-704